Search details
1.
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 2024 Mar 27.
Article
in English
| MEDLINE | ID: mdl-38538060
2.
Economic Evaluations of CAR-T Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review.
Value Health
; 2024 Apr 17.
Article
in English
| MEDLINE | ID: mdl-38641057
3.
Congenic hematopoietic stem cell transplantation promotes survival of heart allografts in murine models of acute and chronic rejection.
Clin Exp Immunol
; 213(1): 138-154, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37004176
4.
Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodies.
Muscle Nerve
; 67(2): 154-157, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36527328
5.
Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.
Mult Scler
; 27(2): 167-173, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32364422
6.
Autologous Hematopoietic Stem Cell Transplantation for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Can J Neurol Sci
; 48(6): 760-766, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33631093
7.
Does Lymphocyte Count Impact Dosing of Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplantation?
Biol Blood Marrow Transplant
; 26(7): 1298-1302, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32165325
8.
Does Resetting the Immune System Fix Multiple Sclerosis?
Can J Neurol Sci
; 47(1): 1-10, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31511117
9.
Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(5): 845-854, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30794930
10.
Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis.
Mult Scler
; 25(13): 1764-1772, 2019 11.
Article
in English
| MEDLINE | ID: mdl-30251913
11.
Effect of Donor Age and Donor Relatedness on Time to Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia.
Biol Blood Marrow Transplant
; 24(12): 2466-2470, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30036572
12.
Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
Mult Scler
; 24(8): 1055-1066, 2018 07.
Article
in English
| MEDLINE | ID: mdl-28617152
13.
Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(12): 2096-2101, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-28821454
14.
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Lancet
; 388(10044): 576-85, 2016 Aug 06.
Article
in English
| MEDLINE | ID: mdl-27291994
15.
Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis.
Mult Scler
; 23(3): 420-431, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-27246142
16.
Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques.
Mol Ther
; 23(6): 1066-1076, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25807289
17.
Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages.
EMBO J
; 30(3): 494-509, 2011 Feb 02.
Article
in English
| MEDLINE | ID: mdl-21179004
18.
Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study.
Br J Haematol
; 191(1): e14-e19, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32688454
19.
Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation.
Transfusion
; 55(2): 253-8, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25125085
20.
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Ann Neurol
; 73(3): 341-54, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23463494